Diabetes – MOSAEC

6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions

An array of obstacles make it difficult for patients to obtain Wegovy or Zepbound. Finding Wegovy is “like winning the lottery,” one nurse practitioner said.

By Reed Abelson and Rebecca Robbins

Diabetes Diet and Nutrition Drugs (Pharmaceuticals) Food Ozempic (Drug) Thanksgiving Day Weight

Thanksgiving Is All About Food. Will Ozempic Make It Better or Worse?

The weight-loss drugs that have swept into the cultural conversation crash into a holiday that’s all about food.

By Dani Blum and Callie Holtermann

Denmark Diabetes Drugs (Pharmaceuticals) Economic Conditions and Trends Gross Domestic Product Novo Nordisk A/S Ozempic (Drug) Semaglutide (Drug) Wegovy

Novo Nordisk’s Ozempic and Wegovy Reshape Denmark’s Economy

Novo Nordisk, the Danish company behind two popular obesity medications, is reaping huge profits and is now responsible for most of the country’s economic growth.

By Eshe Nelson

Diabetes Drugs (Pharmaceuticals) Heart Mikhail Kosiborod New England Journal of Medicine Novo Nordisk A/S Obesity Placebos Research Semaglutide (Drug) Weight

Wegovy, the Weight Loss Drug, Relieves Heart Failure Symptoms: Drugmaker’s Study

The drug Wegovy eased issues for people with a type of heart problem, adding to the treatment’s benefits beyond weight loss.

By Benjamin Mueller

mosaec